Schedule – doses and type of vaccine required to be treated as vaccinated within New Zealand borders

2 doses of Pfizer/BioNTech (Comirnaty, Tozinameran, BNT162b2)

2 doses of Moderna (Spikevax, mRNA-1273)

2 doses of AstraZeneca (Covishield, Serum Institute India formulation)

2 doses of AstraZeneca (Oxford/AstraZeneca, Vaxzevria, AZD1222, ChAdOx1 nCoV-19)

2 doses of Sinopharm, Beijing (BBIBP-CorV, BIBP vaccine, Covilo)

2 doses of Sinovac (CoronaVac, PiCoVacc).

2 doses of Bharat Biotech (Covaxin, BBV152)

2 doses of Covovax (Serum Institute India Novavax formulation)

2 doses of Novavax (Nuvaxovid, NVX-CoC2373)

1 dose of Janssen / Johnson & Johnson (Janssen COVID-19 Vaccine, Ad26.COV2.S1, JNJ-78436735), alone or in combination with any other vaccine

2 doses of any combination of the following:

• Pfizer/BioNTech (Comirnaty, Tozinameran, BNT162b2)
• Moderna (Spikevax, mRNA-1273)
• AstraZeneca (Oxford/AstraZeneca, Vaxzevria, AZD1222, ChAdOx1 nCoV-19)
• AstraZeneca (Covishield, Serum Institute India formulation)
• Sinopharm, Beijing (BBIBP-CorV, BIBP vaccine, Covilo)
• Sinovac (CoronaVac, PiCoVacc)
• Bharat Biotech (Covaxin, BBV152)
• Novavax (Nuvaxovid, NVX-CoC2373)
• Covovax (Serum Institute India Novavax formulation)

If a person has received 1 or more doses (or for Zydus Cadila or Rasi Cov Pars 1, 2 or 3 doses) of any of the following, then 1 additional dose of Pfizer/BioNTech, Moderna, AstraZeneca (Vaxzevria or Covishield) or Janssen vaccine is required to be treated as vaccinated:

• Sinopharm, Wuhan (WIBP-CorV. Inactivated Vero Cells)
• Sputnik V (Gamaleya Research Institute of Epidemiology and Microbiology Gam-COVID-Vac)
• Gamaleya Research Institute of Epidemiology and Microbiology (Sputnik Light)
• Takeda (TAK-919). Note: this is a Moderna formulation
• CanSino (Convidecia, PakVac, Ad5-nCoV)
• Zydus Cadila (ZyCoV-D)
• Anhui Zhifei Longcom (Zifivax, ZF2001, ZF-UZ-VAC-2001)
• Minhai Biotechnology Co (Beijing) (KCONVAC, Minhai COVID-19 vaccine)
• Shifa Pharmed Industrial Co (COVIran Barekat, BIV1-CoVIran)
• Federal Budgetary Research Institution State Research Center of Virology and Biotechnology VECTOR, FBRI (EpiVacCorona, Aurora-CoV)
• Chumakov Centre (KoviVac)
• Khazakstan Research Institute for Biological Safety Problems, RIBSP (QazVac, QazCovid-in)
• Medigen Vaccine Biologics Corporation, MVC (MVC COVID-19 vaccine, MVC-COV1901)
• Center for Genetic Engineering and Biotechnology, CIGB (Abdala, CIGB-66)
• Vaxine/Cinna Gen Co. COVAX-19 (SpikeoGen)
• Biological E. (BioE) Limited (Corbevax, BECOV2D, BECOV2A, BioE COVID-19)
• Federal Budgetary Research Institution State Research Center of Virology and Biotechnology VECTOR, FBRI (EpiVacCorona-N, EpiVacCorona)
• Health Institutes of Turkey (Turkovac, ERUCOV-VAC)
• Instituto Finlay de Vacunas Cuba (Soberana 02, FINLAY-FR-2, Pasteurcovac)
• National Vaccine and Serum Institute, China (Recombinant SARS-COV-2 Vaccine (CHO Cell), NVSI-0608, Recombinant COVID-19 Vaccine (CHO cell, NVSI-06-08))
• Organization of Defensive Innovation and Research, Iran (FAKHRAVAC, MIVAC)
• Razi Vaccine and Serum Research Institute, Iran (Rasi Cov Pars)

If a person has received 2 doses of Instituto Finlay de Vacunas Cuba (Soberana 02, FINLAY-FR-2, Pasteurcovac) and 1 dose of Instituto Finlay de Vacunas Cuba (Soberana Plus, FINLAY-FR-1A), then 1 additional dose of Pfizer/BioNTech, Moderna, AstraZeneca (Vaxzevria or Covishield) or Janssen vaccine is required to be treated as vaccinated.